Global healthcare quarterly: Covid-19 tests industry resilience; might it enhance its reputation?

Presenting Scope Ratings’ latest global healthcare quarterly, head of corporates ratings Olaf Tölke takes a look at the sector’s improved trading outlook after the Covid-19 crisis tested the resilience of hospital sector, some pharma segments mid-year. Tölke will update Scope’s credit outlook for an industry which, with the right coronavirus response, might have an opportunity to enhance its reputation with government and consumers.